Alere, which had a market value of $3.2 billion as of Friday, makes "point of care" medical tests that can provide results in a matter of minutes. The company, based in Waltham, Mass., will become a subsidiary of Abbott, which is expecting to have annual diagnostic sales of $7 billion after the transaction closes, according to a statement released by the companies on Monday.